1. Hardman JG, Limbird LE, Gilman AG. Goodman and Gilman’s ThePharmacological Basis of Therapeutics, 10th ed. New York: McGraw Hill, 2001: 1250-1256.
2. Zhanel GG, Dueck M, Hoban DJ, et al. Review of macrolidesand ketolides: focus on respiratory tract infections. Drugs 2001; 61 (4): 443-498.
3. Zuckerman JM, Quamar F, Bono BR. Macrolides, Ketolides, and Glycylcyclines: Azithromycin, Clarithromycin, Telithromycin, Tigecycline. Infect Dis Clin N Am 2009; 23: 997-1026.
4. Kayaalp O. Makrolid, Linkozamid ve Streptogramin Antibiyotikler ve Linezolid. Akılcıl Tedavi Yonunden Tıbbi Farmakoloji, 13. Baskı. Ankara: Pelikan Yayıncılık, 2012: 217-224.
5. Kanan K, Mankin AS. Macrolide antibiotics in the ribosome exit tunnel: species-specific binding and action. Ann N Y Acad Sci 2011; 1241: 33-47.
6. Nesbitt WJ, Aronoff DM. Macrolides and Clindamycin. In: Bennett JE, Dolin R, Blaser MJ (eds). Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases, 9th ed. Phi-
ladelphia: Churchill Livingstone, 2020: 359-374.
7. Shryock TR, Mortensen JE, Baumholtz M. The effects of macrolides on the expression of bacterial virulence mechanisms. J Antimicrob Chemother 1998; 41: 505-512.
8. Cameron EJ, McSharry C, Chaudhuri R, Farrow S, Thomson NC. Long-term macrolide treatment of chronic inflammatory airway diseases: risks, benefits and future developments. Clin Exper
Allergy 2012; 42 (9): 1302-1312.
9. Gumaste V, Baum J. Treatment of gastroparesis: an update. Digestion 2008; 78 (4): 173-179.
10. Parnham MJ, Erakovic Haber V, Giamarellos-Bourboulis EJ, Perletti G, Verleden GM, Vos R. Azithromycin: mechanisms of action and the irrelevance for clinical applications. Pharmacol
Ther. 2014 Aug;143(2):225-45.
11. Zuckerman JM, Quamar F, Bono BR. Review of Macrolides (Azithromycin, Clarithromycin), Ketolids (Telithromycin), and Glycylcyclines (Tigecycline). Med Clin N Am 2011; 95: 761-791.
12. Giedraitiene A, Vitkauskiene A, Naginiene R, Pavilonis A. Antibiotic resistance mechanisms of clinically important bacteria. Medicina 2011; 47 (3): 137-146.
13. Darkes MJ, Perry CM. Clarithromycin extended-release tablet: a review of itsuse in the management of respiratory tract infections. Am J Respir Med 2003; 2 (2): 175-201.
14. Drusano GL, Craig WA. Antibakteriyel Kemoterapi. Goldman L, Schafer AI (eds), (çeviri editör Ünal S, bölüm). Goldman’s Cecil Medicine (Türkçe Çevirisi). Güneş Tıp Kitapevi, 2015:1803-
1815.
15. Sancar M. Makrolidler ve benzeri antibakteriyel ilaçlar. Şener G, Gören MZ, Okuyan B, Yeğen BÇ.Güncel Farmakoloji. Güneş Tıp Kitapevi,2022:733-735.
16. Owens RC Jr, Donskey CJ, Gaynes RP, Loo VG, Muto CA. Antimicrobial – associated risk factors for Clostridium difficile infection. Clin Infect Dis 2008; 46 (Suppl 1) S19-S31.